Crinetics Pharmaceuticals, Inc. (CRNX) Reports Material Event to SEC

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) filed a Form 8-K with the Securities and Exchange Commission on January 13, 2026, disclosing a material event.

Crinetics Pharmaceuticals, Inc.'s stock currently trades at $0.00 with a market capitalization of $0. The company's stock moved following the disclosure.